What This Check Covers
This guide examines wording and disclosure patterns, not medicine. The goal is narrower: judge whether to reply, click, or submit a form—not whether to enroll. The research base here is platform advertising policy, not clinical or regulatory guidance. Nothing here evaluates a treatment, and no diabetes management decision should change because of a listing or this article; ask your clinician. If you have acute symptoms, seek care first.
A Listing Is Recruitment Copy, Not Proof
A recruiting page is marketing material, not the trial protocol, the consent form, or independent verification. Names, logos, "research center" language, and polished testimonials can imitate credibility without proving it. A sponsor funds or organizes a study, a contract research organization may manage parts, and a site and study coordinator carry out visits; listings often blur those roles. Check what you can: who is legally named, what is promised, and what the page asks you to hand over before a human speaks with you. A polished page cannot verify a study's design or oversight; those are separate checks.
Red Flag 1: Impossible or Absolute Promises
"Free treatment forever," "cash today," "your spot is reserved," and "guaranteed approval" are concrete promises made before eligibility is assessed or participation is explained. A recruiting offer cannot control screening results, so such promises cannot be kept. Google's publisher policy materials treat "free or cash offers," "promise to hire," and "promise of admission" as egregious examples; one egregious violation equals one strike. These are advertising-integrity examples, not court rulings. Your move: ask who is paying, what is conditional, and what the written terms are before scheduling a visit. "No cost to you for study procedures" is narrower than open-ended "free treatment": ask which procedures and visits are covered, and what remains your responsibility. Do not treat an undocumented cash promise as a benefit.
Red Flag 2: Vague Promises and Missing Information
Vague wording can hide the same problem. "Top doctors near you" with no names, "results that speak for themselves," "learn how to reverse diabetes," and a promised list of trials that never appears are hard to evaluate. Google's compliance guidance treats promises that are not clear or explicit, and specific information offered but not made available, as ordinary policy violations; five such violations equal one strike. That classification is about advertising conduct, not study quality. Your move: request the sponsor's name, the site's physical address, and the name of the licensed investigator before sharing anything. If the reply stays vague, or the "list" is only another form, stop.
Red Flag 3: Hidden Identity and Borrowed Credibility
A page should make its publisher and purpose clear. Google's publisher policies disallow ads on content that distorts, misrepresents, or conceals information about the publisher, creator, purpose, or content, and on content that falsely implies an association with or endorsement by another person or organization. Look for a legal entity name, a physical site, and a contact route that is not only a lead form. "Partnered with [big hospital]" without a link or department name, and testimonials styled as medical advice, borrow credibility without proving a relationship. Your move: search the sponsor and site independently, then call the site's published number and ask who is running the study.
Red Flag 4: Pressure Plus Early Data Requests
Urgency is a design choice, not evidence. Countdown timers, "only two slots left today," and a chat window demanding insurance details, payment information, a Social Security number, or full medication history before any call are the pattern to resist. Google's publisher policies describe deceptive behavior as luring users to interact through untrue or ambiguous false content, or promoting products or services through false or deceptive information. That standard addresses presentation, not study quality. Your move: slow down, use the site's published phone number, and ask for a named person and a callback. Never send records or payment details through an ad landing page.
Red Flag 5: When a Trial Page Also Sells a Prescription Product
Research participation and product purchase should be separate steps. Google's publisher restrictions classify content that facilitates the online sale of prescription drugs as restricted content; Google Ads will not serve on content carrying a restriction label, and such content likely receives fewer ads. For a reader, the signal is a "trial" page that also sells, ships, or discounts a prescription product, or routes you to an online pharmacy. A research page may discuss study medication, but screening should not become a purchase funnel. Your move: separate the research question from any buying step. Treat a combined funnel as a stop signal, and do not enter payment details to "confirm eligibility."
Run a Five-Question Screen Before You Respond
Ask five questions: Who is the sponsor? Who is the licensed investigator? What exactly is promised? What is requested from me first? What happens if I say no? Save a screenshot with the date, platform, and exact wording that concerned you. Note the platform and link as part of that screenshot. If the answers are vague, contradictory, or only arrive after you provide insurance or records, wait. Bring the listing and your questions to your own clinician before changing any diabetes treatment. This screen decides whether to engage further, not whether a study is sound.
Limits of This Wording-Based Checklist
Platform advertising policy describes advertising conduct, not scientific quality, regulatory compliance, or your suitability for a study. Policies and enforcement change over time and differ by platform and jurisdiction; the phrases above are illustrative, not exhaustive. This checklist cannot certify that any sponsor, site, or study is legitimate. It can help you slow down, ask better questions, and withhold sensitive information until you independently confirm who you are dealing with.
研究の知恵